[ad_1]
Tribune News Service
Chandigarh, May 9
Two recovered coronavirus patients donated their plasma at the PGI, Chandigarh, on Saturday. This comes after Indian Council of Medical Research (ICMR) approved the IGP to carry out test plasma therapy in patients with COVID-19.
The two donorsFiza Gupta and Arnav Gupta – donated their plasma to support critically ill Covid-19 patients.
IGP The director, Professor Jagat Ram, thanked the family for volunteering for this noble cause.
Recently, the ICMR selected IGP as one of the national centers to conduct the convalescent plasma therapy trial in patients with severe COVID-19 infection.
With this approval, seriously ill patients with COVID-19 admitted to the Nehru Hospital Extension Block will be eligible to receive this form of treatment.
In this test, antibodies from the patients’ blood, which have been recovered from COVID-19, are used to treat severely infected patients.
However, the exact role of this therapy in the treatment of Covid-19 positive patients is still debatable, and therefore the ICMR decided to conduct a multicenter study to clarify its role in these patients.
The collaborative departments for this trial are the departments of internal medicine, anesthesia and intensive care, transfusion medicine, endocrinology, virology, and community medicine.
The team of doctors from the Department of Transfusion Medicine will begin to contact patients who have recovered from COVID-19 infection and explain the nature of the study.
The objective of the study is to evaluate the safety and efficacy of convalescent plasma to limit complications in patients with Covid-19.
[ad_2]
